Learn more

SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD

Overview
  • Total Patents
    206
  • GoodIP Patent Rank
    7,063
  • Filing trend
    ⇧ 31.0%
About

SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD has a total of 206 patent applications. It increased the IP activity by 31.0%. Its first patent ever was published in 2016. It filed its patents most often in WIPO (World Intellectual Property Organization), China and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are EISAI R AND D MAN CO LTD, CONCORTIS BIOSYSTEMS CORP and XTL BIOPHARMACEUTICALS LTD.

Patent filings per year

Chart showing SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Wang Jingyi 200
#2 Wang Lichun 185
#3 Cai Jiaqiang 110
#4 Tian Qiang 90
#5 Song Hongmei 86
#6 Zeng Hong 80
#7 Xue Tongtong 65
#8 Song Shuai 58
#9 Xiao Liang 47
#10 Zhao Mingliang 46

Latest patents

Publication Filing date Title
WO2021063201A1 Anti-pd-1 antibody and use thereof
WO2021047406A1 Tricyclic compound, pharmaceutical composition containing same, preparation method therefor and use thereof
WO2021047407A1 Biaryl compound, pharmaceutical composition comprising same, preparation method therefor, and use thereof
WO2021043077A1 Substituted pyrazine compound and preparation method therefor and use thereof
WO2021057256A1 Heterocyclic nitrogen compound, pharmaceutical composition containing same, preparation method therefor and use thereof
WO2021027594A1 Imidazolopyrimidine compounds comprising fused ring group, preparation method therefor and use thereof
CN112142730A Solid forms of heteroaryltetrahydropyridines and process for their preparation
WO2020238740A1 Solid form of aromatic compound and preparation method therefor
WO2020221038A1 Benzothiophene compound, preparation method therefor and use thereof
WO2020211674A1 Anti-fxi/fxia antibody and use thereof
WO2020207352A1 Triazine benzimidazole compounds and medical use thereof
WO2020207263A1 Benzimidazole compound, preparation method therefor and use thereof
WO2020182018A1 Nitrogen heterocyclic compound, preparation method therefor and use thereof
WO2020173364A1 Oral pharmaceutical composition with azetidine derivative as active ingredient, and preparation method therefor and use thereof
WO2020135210A1 Substituted aryl compound and preparation method therefor and use thereof
WO2020135201A1 Antibody and use thereof
WO2020135195A1 Aminopyridine compound, preparation method therefor and use thereof
WO2020114307A1 Isoxazole derivative, preparation method therefor and use thereof
WO2020108343A1 Oral pharmaceutical composition using 4'-thionucleoside compound as active ingredient, preparation method therefor and use thereof
WO2020098563A1 Pharmaceutical composition comprising polypeptide compound, preparation method therefor and use thereof